Top compounds associated with response to GBP5


Feature Type Standardized
Nominal ANOVA
mRNA purmorphamine CTRPv2 pan-cancer AAC 0.08 0.03
mRNA BRD-K02492147 CTRPv2 pan-cancer AAC 0.085 0.03
mRNA CIL56 CTRPv2 pan-cancer AAC -0.096 0.03
mRNA salermide CTRPv2 pan-cancer AAC 0.096 0.04
mRNA YM201636 GDSC1000 pan-cancer AAC -0.068 0.04
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.075 0.04
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.073 0.04
mRNA AT-7519 GDSC1000 pan-cancer AAC -0.064 0.04
mRNA MK 1775 CTRPv2 pan-cancer AAC 0.07 0.04
mRNA TL-1-85 GDSC1000 pan-cancer AAC 0.065 0.04
Download CSV